Immunoglobulin (Ig)A nephropathy (IgAN) is the most common form of primary glomerulonephritis in the world. Some bacteria were reported to be the candidate of the antigen or the pathogenesis of IgAN, but systematic analysis of bacterial flora in tonsil with IgAN has not been reported. Moreover, these bacteria specific to IgAN might be candidate for the indicator which can predict the remission of IgAN treated by the combination of tonsillectomy and steroid pulse.
Methods and Findings
We made a comprehensive analysis of tonsil flora in 68 IgAN patients and 28 control patients using Denaturing gradient gel electrophoresis methods. We also analyzed the relationship between several bacteria specific to the IgAN and the prognosis of the IgAN. Treponema sp. were identified in 24% IgAN patients, while in 7% control patients (P = 0.062). Haemophilus segnis were detected in 53% IgAN patients, while in 25% control patients (P = 0.012). Campylobacter rectus were identified in 49% IgAN patients, while in 14% control patients (P = 0.002). Multiple Cox proportional-hazards model revealed that Treponema sp. or Campylobactor rectus are significant for the remission of proteinuria (Hazard ratio 2.35, p = 0.019). There was significant difference in remission rates between IgAN patients with Treponema sp. and those without the bacterium (p = 0.046), and in remission rates between IgAN patients with Campylobacter rectus and those without the bacterium (p = 0.037) by Kaplan-Meier analysis. Those bacteria are well known to be related with the periodontal disease. Periodontal bacteria has known to cause immune reaction and many diseases, and also might cause IgA nephropathy.
This insight into IgAN might be useful for diagnosis of the IgAN patients and the decision of treatment of IgAN.
Citation: Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, et al. (2014) Periodontal Disease Bacteria Specific to Tonsil in IgA Nephropathy Patients Predicts the Remission by the Treatment. PLoS ONE 9(1): e81636. doi:10.1371/journal.pone.0081636
Editor: Ali Al-Ahmad, University Hospital of the Albert-Ludwigs-University Freiburg, Germany
Received: July 10, 2013; Accepted: October 15, 2013; Published: January 28, 2014
Copyright: © 2014 Nagasawa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by grant-in-aid for Young Scientists B (21790809), grant–in–aid for Scientific Research C (22590891), grant from Research Conference of IgA nephropathy, and grant from Osaka kidney bank (OK-3, 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Immunoglobulin (Ig)A nephropathy (IgAN) is the most common form of primary glomerulonephritis in the world . It is reported to occupy more than a half of the primary glomerulonephritis . It is characterized by IgA deposition to glomerular mesangial cells in pathological point of view and sometimes macroscopic hematuria after upper respiratory infection in clinical point of view. Since it was firstly reported by Berger in 1968 , the etiology and cause of the disease has been an ultimate mystery , although several genes ,  or single nucleotide polymorphism – were reported to be associated with incidence or progression of IgA nephropathy. In a couple of decades ago, its prognosis was believed to be rather good, but Koyama et al reported that 39% of the patients with IgAN end up in dialysis or death in 20 years , . Recently our group reported that 61% of IgAN patients with smoking reached to the 150% elevation of creatine in 15 years , . Moreover, the occurrence is often seen in the younger generations such as in their teens or twenties, the treatment strategy focusing on the longer term is being a crucial problem.
It is also well known that in upper respiratory infection such as tonsillitis, IgAN patients often manifest the deterioration of urinary findings; macroscopic hematuria . Therefore, tonsillectomy is a focus of much attention in treating IgAN. In the wake of this trend, combination of tonsillectomy and steroid pulse therapy was reported to be effective – and tonsillectomy alone was reported to have a favorable effect to the IgAN . The indicators which can predict the remission of IgAN by the combination therapy become desired in the case of application of this treatment , because there were not any confirmative clinical marker for decision of treatment –. The gene expression and structural difference between the tonsils in patients with IgAN and those in control were reported , . The key factor which induced these kinds of differences in tonsils of IgAN patients may be infection. Some bacteria were reported to be the candidate of the antigen or the pathogenesis of IgAN –, but systematic analysis of bacterial flora in tonsil with IgAN has not been reported. Moreover, these bacteria specific to IgAN might be candidate for the indicator which can predict the remission of IgAN.
We performed tonsillectomy combined with steroid pulse as a treatment to IgAN,and we made a comprehensive analysis of tonsil flora in IgAN patients using Denaturing gradient gel electrophoresis (DGGE) methods. We also analyzed the relationship between several bacteria specific to the IgAN and the prognosis of the IgAN.
Materials and Methods
Tonsil tissues of the IgAN patients were obtained from 104 consecutive patients undergoing tonsillectomy at Osaka university hospital from April, 2004 to January, 2008. A pair of palatine tonsils was resected when tonsillectomy. One of tonsils was used for clinical histological evaluation. Another of tonsils was used for this study. More than half of the tonsil was used for RNA extraction. The diagnosis of the IgAN in these patients was made by the renal biopsy. The 28 control tonsil tissues were obtained from the patients suffering from chronic tonsillitis at tonsillectomy. Inclusion criteria for DGGE analysis in IgAN patients comprised age 18 to 65 years, serum creatinine at tonsillectomy of = <2.0 mg/dl, and urinary protein > = 0.3 g/gCr. Exclusion criteria comprised use of steroid and/or other immunosuppressive agents at tonsillectomy. Accordingly, 68 patients were eligible for DGGE analysis. For survival analysis in IgAN patients, we excluded patients of follow up period <6 months, and patients without hematuria at tonsillectomy. Therefore, 59 patients were eligible for survival analysis. IgAN patients received tonsillectomy and 7 days later received intravenous steroid pulse therapy (methylprednisolone pulses of 500 mg/day) for three days, followed by oral prednisolone at an initial dose of 1 mg/kg for 11days. Then, patients received intravenous steroid therapy again for three days, followed by oral prednisolone at a dose of 30 mg/day and gradually tapered by 5–10 mg/1–2 months and discontinued within about one year. This treatment protocol was slightly weaker than the protocol used by Pocci et al , , . Remission of urinary protein and that of urinary occult blood were defined as negative or almost negative, twice by dipstick at least in one month interval.
Written informed consent was obtained from all participating subjects. This study was approved by the ethical committee of Osaka University Graduate School of Medicine.
In order to evaluate the bacterial flora in tonsil, we performed DGGE analysis using cDNA. The tonsil tissue was homogenized; total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA, US) and 0.4 microgram of RNA was converted to cDNA using random primers and SuperScript II (Invitrogen, Carlsbad, CA). For PCR-DGGE analyses, each cDNA sample was amplified by PCR with universal bacterial primers 954f (cgcccgccgcgccccgcgcccggcccgccgcccccgccccgcacaagcggtggagcatgtgg) and 1396r (GCCCGGGAACGTATTCACCG) specific for V6 to V8 regions of the 16S rRNA gene . The reaction mixtures and PCR conditions were referred to previous report .
After confirmation of the PCR product with agarose gel electrophoresis, DGGE was performed with the DCode universal mutation detection System (Bio-Rad laboratories). Polyacrylamide gel conditions for denaturing gradient, migration and differentiation were referred to previous report . The electrophoresis was conducted with constant voltage of 82 V at 60°C for 15 h. Gels were stained with SYBR Green I (Lonza, Rockland, ME), and acquired by GelDoc XR (Bio-Rad laboratories).
Statistical analysis of DGGE image
The DGGE image was read by Quantity One software (BioRad) and the intensity and position of bands in each lanes ware read into a spectrum of 100 variables. Partial least squares discriminant analysis (PLS-DA), a regression extension of the classical Principal Component Analysis appropriate to our dataset, was run with the R software using the pls package (ver 2.0) and the “simpls” method . Briefly, the DGGE band dataset was imported into the R software, and variance and regression were computed in a class-supervised manner and principal components (PC) scores. Data were visualized as PC score plots, with the PC1 axis exhibiting most of the differences among the samples, while PC2 and PC3 corresponded to factors with decreasing contribution to the differences. Each coordinate on the scores plot represents an individual sample and each coordinate on the loadings plots represents DGGE gel position of bands. Thus, the loadings plots provide information on band position responsible for the position of coordinates or clusters of samples in the corresponding scores plots.
Identification of bacterial origin
There were 3 bands in the DGGE analysis which characterized the flora in tonsils of the patients with IgAN. For identification of DNA sequences of bacterial origin in the gel, selected DGGE bands were excised from original gels and their DNA fragments were reamplified with corresponding primers. The obtained PCR product was purified, cloned by TA cloning method using TA cloning Kit as manufacture's instruction (INVITOROGEN, Life Technologies, Carlsbad, CA). The clones were sequenced as described in previous report . The sequences were submitted to BLAST search programs in DDBJ (DNA Data Bank of Japan) to determine their closest relatives.
Histological evaluation was performed according to the Oxford classification , . The four pathological variables of Oxford classification were evaluated: mesangial hypercellularity score≤0.5 or >0.5, presence or absence of segmental sclerosis or adhesion, presence or absence of endocapillary hypercellularity, and tubular atrophy/interstitial fibrosis ≤25%, 26–50%, or >50%.
Normally distributed continuous variables were expressed as mean±SD, and non-normally distributed continuous variables as median (interquartile range). Categorical variables were expressed as numbers (proportions). For comparison between two groups, the t-test was used for normally distributed continuous variables, the Mann-Whitney test for non-normally distributed continuous variables, and χ2 test for categorical variables. Kaplan-Meier analysis using log-rank test was used to compare survival rate. We used the Cox proportional hazards model to assess the impact of covariates for the remission of urinary protein and urinary occult blood. The results of the analyses are expressed as hazards ratios with 95% confidence intervals and a P value. P values less than 0.05 were considered statistically significant. All statistical analyses were performed using JMP for windows version 8.0.1 (SAS Institute Inc., Cawy, NC, US).
Clinical characteristics of 68 IgA nephropathy patients and 28 control patients are presented in Table 1. Mean glomerular filtration rate (GFR) in IgA nephropathy patients was 85 ml/min, while mean GFR in control group was 124 ml/min. GFR was calculated using GFR estimated equation . Urinary protein in IgA nephropathy patients was 0.59 (0.38 to 1.04) g/day. There were no significant difference except serum creatinine and eGFR between IgA nephropathy patients and control patients.
All samples including 68 tonsils with IgAN patients and 28 tonsils with control patients were analyzed by PCR-DGGE method followed by PLS-DA. The patterns of the bands in DGGE analysis were scanned and PLS-DA was performed based on the intensity and position of the bands in each lane as shown in Figure 1A. Based on the PLS-DA, 3 bands strongly contributed to the feature of the IgAN, which were shown in original gel in Figure 1B.
Result of PLS-DA on DGGE band data set of each control (red) and IgA nephropathy patient (blue) are shown (n = 68 and 28, respectively). Proportions of the first (PC1), second (PC2), and third (PC3) components are 50.1%, 13.3%, and 3.78%, respectively. (B) Results of PCR-Denaturing gradient gel electrophoresis (DGGE) analysis: Specific DGGE bands in IgA nephropathy patients were shown as A, B, and C.
These 3 bands were cloned and Bacteria A, B, and C shown in Figure 1B were identified as Treponema sp., Haemophilus segnis, and Campylobacter rectus, respectively. Treponema sp. were identified in 24% IgAN patients, while the bacteria were identified in 7% control patients (P = 0.062). Haemophilus segnis were detected in 53% IgAN patients, while the bacteria were identified in 25% control patients (P = 0.012). Campylobacter rectus were identified in 49% IgAN patients, while the bacteria were identified in 14% control patients (P = 0.002).
The IgAN patients were divided by the presence or absence of the each bacterium, and the patient characteristics were compared between two groups in each bacterium (Table 2). Basically there were no significant difference between IgA nephropathy patients with bacterium and those without bacterium.
Univariate Cox proportional-hazards model for proteinuria revealed that the Campylobacter rectus is the significant factor for the remission of proteinuria (Hazard ratio 1.96, p = 0.041) along with the urinary protein level as known before. Treponema sp. is the marginally significant factor for the remission of proteinuria (Hazard ratio 2.08, p = 0.067). Campylobacter rectus or Treponema sp. is the strong factor for the remission of proteinuria (Hazard ratio 2.35, p = 0.011). Multiple Cox proportional-hazards model for proteinuria also revealed that Treponema sp. is significant factor for the remission of proteinuria along with proteinuria in Model 1 in table 3 (hazard ratio 2.62, p = 0.034), and that Campylobacter rectus is marginally significant factor (Hazard ratio 1.86, p = 0.066). Treponema sp. or Campylobactor rectus are significant for the remission of proteinuria along with urinary protein in Model 2 in Table 3 (Hazard ratio 2.35, p = 0.019).
The remission rates of proteinuria between patients with bacteria and those without bacteria were analyzed by Kaplan-Meier analysis using log-rank test (Figure 2).
Differences in urinary protein remission with or without bacterial flora were compared using Kaplan-Meier curves and tested using log-rank. P<0.05 was considered to be statistically significant.
Univariate Cox proportional-hazards model for hematuria revealed that the Campylobacter rectus is the significant factor for the remission of occult blood (Hazard ratio 2.35, p = 0.029). Treponema sp. is also the significant factor for the remission of hematuria (Hazard ratio 4.27, p = 0.004). Campylobacter rectus or Treponema sp. are the strong factor for the remission of hematuria (Hazard ratio 4.54, p<0.001). Multiple Cox proportional-hazards model for hematuria also revealed the similar results as the model for proteinuria (Table 4). The remission rates of hematuria were also analyzed by Kaplan-Meier analysis using log-rank test. The results were similar to the results of the remission rate of proteinuria (Figure 3).
Differences in urinary occult blood remission with or without bacterial flora were compared using Kaplan-Meier curves and tested using log-rank. P<0.05 was considered to be statistically significant.
To know whether these bacteria might be related to pathological features which were important predictor of renal prognosis, we evaluated the association between bacteria detected by DGGE analysis and histopathological factors. We scored 30 patients who were performed renal biopsy within a year of tonsillectomy by using oxford classification and compared the scores with clinical features and bacteria. The prevalence of each component of Oxford classification was summarized in Table S1 in Supplementary Tables. We found that there was no relationship between bacteria and histological factors (Table S2, S3 in Supplementary Tables).
In this study, we comprehensively compared the bacterial flora of the tonsil between IgAN and chronic tonsillitis patients using PCR-DGGE and PLS-DA, and revealed that Treponema sp., Haemophilus segnis, and Campylobacter rectus are specific to IgAN patients. Moreover, we found the remission rates of proteinuria and hematuria were significantly related with the prevalence infection of Treponema sp. and Campylobacter rectus, both of which were reported to be the cause of periodontal disease –, while the existence of Haemophilus segnis had no relationship with clinical course. This result suggests that the detection of bacteria by DGGE analysis could predict the therapeutic effect of tonsillectomy and steroid pulse therapy, and they might reflect the abnormal mucosal immunity in tonsil.
One of clinical manifestations of the IgAN is the macrohematuria soon after the tonsillitis. This feature indicated the relationship between infection in tonsils and IgAN. Haemophilus parainfluenzae was reported to be more commonly isolated from the pharynx of patients with IgAN than from those with other diseases . In this studies, Haemophilus parainfluenzae was confirmed by cultural and antibody methods. These methods could detect the Haemophilus segnis as Haemophilus parainfluenzae, because of antigen similarity . In our study, tonsils with 53% of IgA patients might be infected by Haemophilus segnis which are same as the previous reports , . There is no report that the relationship between Haemophilus parainfluenzae and the prognosis of IgAN, which is compatible with our results.
Treponema sp. and Campylobacter rectus were newly detected bacteria to be associated with IgAN in this report. These bacteria belong to the anaerobic bacterium species and were reported to be the cause of periodontal disease –. This is the reason why these two bacteria could not be detected by the usual culture method in the previous reports in IgAN research . The method we employed in this study is DGGE method, which make it possible for us to detect comprehensive bacterial flora, including anaerobic bacteria. In the young generation, especially in babyhood, human beings are usually free from periodontal bacteria, and also free from IgAN. Campylobacter rectus get dominant from the age of nine in the periodontal area, and Treponema denticola and Treponema forsythensis gets dominant from the age of five . Kappa statistic analysis between these periodontal bacteria in mother and those in children showed high value, suggesting that mother and children often have the same periodontal bacteria . This might explain that IgAN sometimes can be seen in the same family, although the gene related with IgAN can also partially explain this phenomenon .
These are two interpretations of the relationship between those three bacteria and IgAN. One possibility is that these three bacteria have causality of IgAN. The membrane antigens of Haemophilus parainfluenzae was reported to induce the IgAN in mice from 30 to 40 weeks of age . Our data suggested that Treponema sp. and Campylobacter rectus which could cause periodontal disease have stronger association with IgAN, so there is possibility that these two bacteria might have stronger causality of IgAN than Haemophilus parainfluenzae. Periodontal disease was reported to have an interaction between bacterial infection in periodontal area and the degree of the systemic inflammatory response . In addition, the activation of the toll like receptor (TLR) 9 which recognizes bacterial CpG-DNA was reported to affect the severity of IgAN , and constitutive TLR signaling by intestinal commensal microflora caused glomerulonephritis . These reports speculate that interaction between host immune system and bacteria, which cause constitutive stimulation of TLR in the tonsil, might cause IgAN.
The second possibility is that these bacteria are simply associated with IgAN. Tonsil in the patients with IgAN had several features, such as structural changes  and gene expression change , resulting in the change of immune response , –. Those immune changes in tonsil might allow the specific bacteria to grow in tonsil, such as these three bacteria. In this explanation, the existence of these thee bacteria might be a result of the tonsil condition in IgAN.
Recently many reports suggested that periodontal disease associates with atherosclerosis diseases such as coronary artery disease – and progression of chronic renal disease , . Basically, the relationship between atherosclerosis diseases and periodontal diseases are explained by the inflammatory mechanism . There are also several reports suggesting the relationship between the periodontal disease and autoimmune disease such as rheumatoid arthritis , . This relationship was explained by autoimmune response to the periodontal bacteria . The periodontal bacteria were directly detected in athermanous plaque , . The component of streptococcus was reported to be directly involved in hemorrhage stroke . These reports suggested the periodontal disease might have more pathogenicity than chronic inflammatory response. Moreover, some periodontal pathogen directly altered T-cell response . Our data suggested that the periodontal bacteria might have strong association with IgAN, one of most common renal disease rather than with histological components. The continued infections by these periodontal bacteria might stimulate IgA production by T cells in tonsil, resulting in the IgA which has some errors in their glycosylation. The IgA with abnormal glycosylation had been reported to have ability to bind to the glomeruli in IgA nephropathy , . The tonsillectomy and steroid pulse might normalize the IgA production and glycosylation of IgA , resulting in the remission of IgA nephropathy. Therefore, these bacteria might be associated with IgA nephropathy and its clinical course after treatment.
In this study, there are several limitations. First, this study is designed as the retrospective manner. Prospective study should be designed to confirm these results, although the tonsils from IgA patients were obtained before the clinical outcomes including urinary protein and hematuria are confirmed. Second, it is hard to distinguish causality from association according to the relationship between the bacteria specific to IgAN and clinical course, as described above. Further study is required to confirm that these bacteria might cause IgAN in experimental mice. However, this study showed that these bacteria are located at least close to the origin of IgAN. Third, Treponema sp. includes many species. According to our data, Treponema sp. might be Treponema denticola, but it is not confirmative. Although it is hard to identify the bacteria from Treponema sp., the basic relationship between the bacteria and the clinical course or IgAN itself is confirmative from our data. Forth, there is some possibility that some unknown factors might attenuate the PCR efficacy in DGGE analysis of tonsil flora, although the primers which used in our study are standard primer in this method . There was no report which confirmed the PCR efficacy in DGGE method in tonsil flora analysis, although we compared the results of DGGE analysis in tonsils with IgA nephropathy to those with tonsillitis, so the effect of unknown factors should be counterbalanced by the comparison step.
In conclusion, Treponema sp., Haemophilus parainfluenzae, Campylobacter rectus are specific to the tonsils in patients with IgAN. The existence of Treponema sp and Campylobacter rectus in tonsil is the strong and significant indicator of remission of IgAN treated with tonsillectomy and steroid pulse. This insight into IgAN might be useful for diagnosis of the IgAN patients and the decision of treatment of IgAN.
Table S1. Pathologic features in patients diagnosed IgA nephropathy by renal biopsy within a year of tonsillectomy (n = 30). Table S2. Clinical characteristics in patients diagnosed IgA nephropathy by renal biopsy within a year of tonsillectomy according to mesangial hypertrophy and endocapillary hypercellularity. Table S3. Clinical characteristics in patients diagnosed IgA nephropathy by renal biopsy within a year of tonsillectomy according to segmental glomerulosclerosis and tubular atrophy/interstitial fibrosis.
Conceived and designed the experiments: YN KI SF RY AH YI. Performed the experiments: YN KI SF YD HI AH. Analyzed the data: KI SF YD RY. Contributed reagents/materials/analysis tools: YN HI RY AH HI TN HO HR EI YI. Wrote the paper: YN KI SF HI RY AH TN HO HR EI YI.
- 1. Pettersson E (1997) IgA nephropathy: 30 years on. J Intern Med 242: 349–353.
- 2. Nair R, Walker PD (2006) Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 69: 1455–1458.
- 3. Berger J, Hinglais N (1968) [Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris) 74: 694–695.
- 4. Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368: 2402–2414.
- 5. Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, et al. (2012) Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet 8: e1002765.
- 6. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, et al. (2011) Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43: 321–327.
- 7. Holmes LV, Strain L, Staniforth SJ, Moore I, Marchbank K, et al. (2013) Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32. PLoS One 8: e60352.
- 8. Zhou XJ, Cheng FJ, Qi YY, Zhao YF, Hou P, et al. (2013) FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy. PLoS One 8: e61208.
- 9. Yamamoto R, Nagasawa Y, Shoji T, Katakami N, Ohtoshi K, et al. (2012) A candidate gene approach to genetic contributors to the development of IgA nephropathy. Nephrol Dial Transplant 27: 1020–1030.
- 10. Shinzawa M, Yamamoto R, Nagasawa Y, Shoji T, Obi Y, et al. (2012) Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy. Clin Exp Nephrol 16: 250–258.
- 11. Yamamoto R, Nagasawa Y, Shoji T, Inoue K, Uehata T, et al. (2009) A candidate gene approach to genetic prognostic factors of IgA nephropathy–a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN). Nephrol Dial Transplant 24: 3686–3694.
- 12. Vuong MT, Gunnarsson I, Lundberg S, Svenungsson E, Wramner L, et al. (2010) Genetic risk factors in lupus nephritis and IgA nephropathy–no support of an overlap. PLoS One 5: e10559.
- 13. Koyama A, Igarashi M, Kobayashi M (1997) Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 29: 526–532.
- 14. Lee H, Kim DK, Oh KH, Joo KW, Kim YS, et al. (2012) Mortality of IgA nephropathy patients: a single center experience over 30 years. PLoS One 7: e51225.
- 15. Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, et al. (2010) Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis 56: 313–324.
- 16. Nagasawa Y, Yamamoto R, Rakugi H, Isaka Y (2012) Cigarette smoking and chronic kidney diseases. Hypertens Res 35: 261–265.
- 17. Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med 347: 738–748.
- 18. Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, et al. (2001) Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 38: 736–743.
- 19. Miyazaki M, Hotta O, Komatsuda A, Nakai S, Shoji T, et al. (2007) A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report. Contrib Nephrol 157: 94–98.
- 20. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, et al. (2008) Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol 3: 1301–1307.
- 21. Xie Y, Nishi S, Ueno M, Imai N, Sakatsume M, et al. (2003) The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int 63: 1861–1867.
- 22. Appel GB, Waldman M (2006) The IgA nephropathy treatment dilemma. Kidney Int 69: 1939–1944.
- 23. Xie J, Kiryluk K, Wang W, Wang Z, Guo S, et al. (2012) Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS One 7: e38904.
- 24. Kim SJ, Koo HM, Lim BJ, Oh HJ, Yoo DE, et al. (2012) Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One 7: e40495.
- 25. Zhou YH, Tang LG, Guo SL, Jin ZC, Wu MJ, et al. (2011) Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis. PLoS One 6: e18788.
- 26. Iio K, Nagasawa Y, Iwatani H, Yamamoto R, Horii A, et al. (2010) Microarray analysis of tonsils in immunoglobulin A nephropathy patients. Biochem Biophys Res Commun 393: 565–570.
- 27. Xie Y, Chen X, Nishi S, Narita I, Gejyo F (2004) Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int 65: 1135–1144.
- 28. Suzuki S, Nakatomi Y, Sato H, Tsukada H, Arakawa M (1994) Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 343: 12–16.
- 29. Kusano K, Tokunaga O, Ando T, Inokuchi A (2007) Helicobacter pylori in the palatine tonsils of patients with IgA nephropathy compared with those of patients with recurrent pharyngotonsillitis. Hum Pathol 38: 1788–1797.
- 30. Iwama H, Horikoshi S, Shirato I, Tomino Y (1998) Epstein-Barr virus detection in kidney biopsy specimens correlates with glomerular mesangial injury. Am J Kidney Dis 32: 785–793.
- 31. Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, et al. (1999) Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 353: 883–887.
- 32. Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, et al. (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15: 157–163.
- 33. Yu Z, Morrison M (2004) Comparisons of different hypervariable regions of rrs genes for use in fingerprinting of microbial communities by PCR-denaturing gradient gel electrophoresis. Appl Environ Microbiol 70: 4800–4806.
- 34. Muyzer G, Brinkhoff T, Nübel U, Santegoeds C, Schäfer H, et al. (1998) Denaturant gradient gel electrophoresis in microbial ecology. Molecular Microbial Ecology Manual, Vol 344 (Akkermans, A, van Elsas, J D and de Bruijin, F, eds).
- 35. Tian C, Chikayama E, Tsuboi Y, Kuromori T, Shinozaki K, et al. (2007) Top-down phenomics of Arabidopsis thaliana: metabolic profiling by one- and two-dimensional nuclear magnetic resonance spectroscopy and transcriptome analysis of albino mutants. J Biol Chem 282: 18532–18541.
- 36. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, et al. (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76: 534–545.
- 37. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, et al. (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76: 546–556.
- 38. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, et al. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247–254.
- 39. Thompson SA (2002) Campylobacter surface-layers (S-layers) and immune evasion. Ann Periodontol 7: 43–53.
- 40. Okuda K, Kimizuka R, Katakura A, Nakagawa T, Ishihara K (2003) Ecological and immunopathological implications of oral bacteria in Helicobacter pylori-infected disease. J Periodontol 74: 123–128.
- 41. Siqueira JF Jr, Rocas IN (2004) Treponema species associated with abscesses of endodontic origin. Oral Microbiol Immunol 19: 336–339.
- 42. Lau SK, Woo PC, Mok MY, Teng JL, Tam VK, et al. (2004) Characterization of Haemophilus segnis, an important cause of bacteremia, by 16S rRNA gene sequencing. J Clin Microbiol 42: 877–880.
- 43. Ogura Y, Suzuki S, Shirakawa T, Masuda M, Nakamura H, et al. (2000) Haemophilus parainfluenzae antigen and antibody in children with IgA nephropathy and Henoch-Schonlein nephritis. Am J Kidney Dis 36: 47–52.
- 44. Kobayashi N, Ishihara K, Sugihara N, Kusumoto M, Yakushiji M, et al. (2008) Colonization pattern of periodontal bacteria in Japanese children and their mothers. J Periodontal Res 43: 156–161.
- 45. Gharavi AG, Yan Y, Scolari F, Schena FP, Frasca GM, et al. (2000) IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26: 354–357.
- 46. Yamamoto C, Suzuki S, Kimura H, Yoshida H, Gejyo F (2002) Experimental nephropathy induced by Haemophilus parainfluenzae antigens. Nephron 90: 320–327.
- 47. D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, et al. (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83: 156–160.
- 48. Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, et al. (2008) Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 19: 2384–2395.
- 49. Kawagoe T, Takeuchi O, Takabatake Y, Kato H, Isaka Y, et al. (2009) TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol 10: 965–972.
- 50. Kennel-De March A, Bene MC, Hurault de Ligny B, Kessler M, Faure GC (1997) Enhanced expression of CD31 and CD54 on tonsillar high endothelial venules in IgA nephropathy. Clin Immunol Immunopathol 84: 158–165.
- 51. Kodama S, Suzuki M, Arita M, Mogi G (2001) Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis. Clin Exp Immunol 123: 301–308.
- 52. Goto T, Bandoh N, Yoshizaki T, Nozawa H, Takahara M, et al. (2008) Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Clin Immunol 126: 260–269.
- 53. Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, et al. (2000) Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med 160: 2749–2755.
- 54. Genco RJ, Trevisan M, Wu T, Beck JD (2001) Periodontal disease and risk of coronary heart disease. Jama 285: 40–41.
- 55. Arbes SJ Jr, Slade GD, Beck JD (1999) Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 78: 1777–1782.
- 56. Nakajima T, Yamazaki K (2009) Periodontal disease and risk of atherosclerotic coronary heart disease. Odontology 97: 84–91.
- 57. Xu F, Lu B Prospective association of periodontal disease with cardiovascular and all-cause mortality: NHANES III follow-up study. Atherosclerosis 218: 536–542.
- 58. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, et al. (2012) Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation 125: 2520–2544.
- 59. Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, et al. (2005) Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study. Am J Kidney Dis 45: 650–657.
- 60. Craig RG, Kotanko P, Kamer AR, Levin NW (2007) Periodontal diseases–a modifiable source of systemic inflammation for the end-stage renal disease patient on haemodialysis therapy? Nephrol Dial Transplant 22: 312–315.
- 61. Detert J, Pischon N, Burmester GR, Buttgereit F (2010) The association between rheumatoid arthritis and periodontal disease. Arthritis Res Ther 12: 218.
- 62. Pischon N, Pischon T, Kroger J, Gulmez E, Kleber BM, et al. (2008) Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol 79: 979–986.
- 63. Ali J, Pramod K, Tahir MA, Ansari SH Autoimmune responses in periodontal diseases. Autoimmun Rev 10: 426–431.
- 64. Nakano K, Wada K, Nomura R, Nemoto H, Inaba H, et al. Characterization of aortic aneurysms in cardiovascular disease patients harboring Porphyromonas gingivalis. Oral Dis 17: 370–378.
- 65. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr, Progulske-Fox A (2005) Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 25: e17–18.
- 66. Khalaf H, Bengtsson T (2012) Altered T-cell responses by the periodontal pathogen Porphyromonas gingivalis. PLoS One 7: e45192.
- 67. Novak J, Julian BA, Mestecky J, Renfrow MB (2012) Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol 34: 365–382.
- 68. Iwatani H, Inoue T, Wada Y, Nagasawa Y, Yamamoto R, et al. (2012) Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy. Biochem Biophys Res Commun 428: 339–342.